News from boston scientific corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 30, 2023, 16:30 ET Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock

Boston Scientific Corporation (NYSE: BSX) announced today that its Series A 5.50% Mandatory Convertible Preferred Stock (the preferred stock) will...

May 20, 2023, 14:54 ET Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management...

May 15, 2023, 09:00 ET Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference

Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023. Mike ...

Apr 26, 2023, 06:30 ET Boston Scientific Announces Results for First Quarter 2023

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported...

Apr 03, 2023, 09:30 ET Boston Scientific Announces Conference Call Discussing First Quarter 2023 Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ...

Feb 13, 2023, 09:30 ET Boston Scientific to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference

Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Wednesday, March...

Feb 03, 2023, 06:45 ET Boston Scientific Receives FDA Clearance for LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System

Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use...

Feb 01, 2023, 06:30 ET BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported...

Jan 03, 2023, 09:30 ET Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2022 Results

Boston Scientific Corporation (NYSE: BSX) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 in San ...

Dec 11, 2022, 17:17 ET Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited

Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will...

Nov 29, 2022, 07:00 ET Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. (Nasdaq:...

Nov 27, 2022, 12:05 ET Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2™ Aortic Valve System

Boston Scientific Corporation (NYSE:BSX) has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating ...

Nov 01, 2022, 09:30 ET Boston Scientific Announces Upcoming Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On November 15, 2022, Dan Brennan, executive vice...

Oct 26, 2022, 06:30 ET Boston Scientific Announces Results for Third Quarter 2022

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.170 billion during the third quarter of 2022, growing 8.1 percent on a reported...

Oct 03, 2022, 09:30 ET Boston Scientific Announces Conference Call Discussing Third Quarter 2022 Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ...

Sep 17, 2022, 11:21 ET Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System

Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection...

Sep 06, 2022, 06:55 ET Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use labeling...

Aug 16, 2022, 14:00 ET Boston Scientific Announces Upcoming Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor events. On Wednesday, September 7, 2022, Mike Mahoney, chairman...

Aug 15, 2022, 07:00 ET Boston Scientific Announces Acquisition of Obsidio, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel...

Jul 27, 2022, 06:30 ET Boston Scientific Announces Results for Second Quarter 2022

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.244 billion during the second quarter of 2022, growing 5.4 percent on a reported...

Jun 29, 2022, 09:30 ET Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second...

Jun 15, 2022, 07:00 ET Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to...

May 02, 2022, 09:30 ET Boston Scientific to Participate in Bank of America Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) will participate in Bank of America's Global Healthcare Conference on Thursday, May 12. Dan Brennan,...

Apr 27, 2022, 06:30 ET BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing 10.0 percent on a reported...

Apr 01, 2022, 09:00 ET Boston Scientific Announces Conference Call Discussing First Quarter 2022 Results

Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial results and business highlights for the first quarter...